Inhibiting epidermal growth factor receptor improves structural, locomotor, sensory, and bladder recovery from experimental spinal cord injury.
about
The Role of Astrocytes in Multiple Sclerosis ProgressionResearch Findings on Overactive BladderEGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALSRat models of spinal cord injury: from pathology to potential therapiesThe blood-spinal cord barrier: morphology and clinical implicationsInhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injuryThe mechanisms of EGFR in the regulation of axon regenerationSpinal Cord InjuryThe extracellular matrix glycoprotein tenascin-C is beneficial for spinal cord regeneration.Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injuryTGF-alpha increases astrocyte invasion and promotes axonal growth into the lesion following spinal cord injury in mice.Decorin treatment of spinal cord injuryTreatment with Anti-EGF Ab Ameliorates Experimental Autoimmune Encephalomyelitis via Induction of Neurogenesis and OligodendrogenesisTransforming growth factor α transforms astrocytes to a growth-supportive phenotype after spinal cord injuryModifying effect of intravenous laser therapy on the protein expression of arginase and epidermal growth factor receptor in type 2 diabetic patients.RegenBase: a knowledge base of spinal cord injury biology for translational researchValidity of acute and chronic tactile sensory testing after spinal cord injury in rats.Axon regeneration in the peripheral and central nervous systems.Signaling pathways in reactive astrocytes, a genetic perspective.Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects.Nogo-A represses anatomical and synaptic plasticity in the central nervous system.Scar-modulating treatments for central nervous system injury.Nucleolin inhibitor GroA triggers reduction in epidermal growth factor receptor activation: Pharmacological implication for glial scarring after spinal cord injury.The total synthesis of a ganglioside Hp-s1 analogue possessing neuritogenic activity by chemoselective activation glycosylation.New platform for controlled and sustained delivery of the EGF receptor tyrosine kinase inhibitor AG1478 using poly(lactic-co-glycolic acid) microspheres.Brain Metal Distribution and Neuro-Inflammatory Profiles after Chronic Vanadium Administration and Withdrawal in Mice.Receptor tyrosine kinases: molecular switches regulating CNS axon regeneration.The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord.LINGO-1, WNK1, and EGFR: a hypothesis.ErbB1 epidermal growth factor receptor is a valid target for reducing the effects of multiple inhibitors of axonal regeneration.Off-target effects of epidermal growth factor receptor antagonists mediate retinal ganglion cell disinhibited axon growth.Epiregulin and EGFR interactions are involved in pain processing.Leptin suppresses adenosine triphosphate-induced impairment of spinal cord astrocytes.Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.FOXO3a involvement in the release of TNF-α stimulated by ATP in spinal cord astrocytes.Cotransplantation of glial restricted precursor cells and Schwann cells promotes functional recovery after spinal cord injury.The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.The neuronal differentiation microenvironment is essential for spinal cord injury repair.Inhibition of Epidermal Growth Factor Receptor Improves Myelination and Attenuates Tissue Damage of Spinal Cord Injury.Blocking epidermal growth factor receptor attenuates reactive astrogliosis through inhibiting cell cycle progression and protects against ischemic brain injury in rats.
P2860
Q26782843-079F4C7F-95CC-465B-91FD-347765A99579Q26801459-84824169-44FC-4589-B7EA-DB464AC0CB94Q27322781-682429A2-157D-4714-873C-10DE0063396FQ28071816-4903FAA2-D42F-4E78-B490-2A380EA22797Q28240807-306D5F3F-BB4F-4E1E-9165-D5F1EB021187Q28574797-35C5E67B-8324-459C-9079-C839C1B9BDACQ28577674-EC8C48CF-250A-4B07-8ED5-E6EA40A50593Q30225500-F38852DC-09DA-4EE4-8677-48444253CB2CQ30496905-38A34BED-4891-40A3-9F58-DB3A2CE8D125Q33647461-C9185A8E-2741-40E2-84AF-3F8ED86DDF39Q33956900-E2526ACF-5C2E-43F5-BB59-692E79AE7B25Q34412717-E4D6181C-1057-46F3-964D-DB1848F2A376Q34970564-3BE0C8A4-B520-4837-B136-51E82B04D8FDQ35543006-DE35CF7D-B069-4C04-B881-BA3C5FCBAE71Q36074410-D18F4DE5-ACC4-46DD-A878-06CA1C81C7A5Q36774566-DD4C68D3-4C11-45B8-8063-75DC3DC675D8Q37065365-FA4EFC07-28F6-4F0B-B136-B82815F241C4Q37543100-1CC14CAE-30A4-45DF-99BE-C4AE79950105Q37828480-54ECB429-16E7-4B3F-8F64-1C0060162150Q38017625-AC7D321F-E8CE-48CF-A91B-525EBDC66B64Q38103436-59506DAA-E9B6-4F06-B7EB-6234582A1CCBQ38222632-8D4A12AD-F4CC-4ED1-9503-3AF3BDBD59D5Q38291753-578503B2-CFBE-4F7C-B2AD-43304E4F390EQ39426299-8CA705F0-30BE-4D83-AA9C-DC3DBA9A8E8BQ39754858-4B181B91-EDF4-4F9F-8D16-DE2546E60092Q41108059-171229B0-12EB-4131-ACBB-8FB89D6125B2Q41819306-5FCF9318-6EAB-4909-89DD-BDB6B4A9992AQ41957358-8FFD0056-16AE-4FBB-B676-B74697657E38Q42681347-A3FE5FDA-97BF-47BF-B489-A65D3BA78021Q43031168-16144EA6-2529-4425-9926-8916E476BFBFQ43270642-08C274D4-0D4D-4FCB-9820-6B755815452CQ47265974-E23F7B29-1DE7-4369-923A-DF6045FFD0EFQ47299971-BAE5B395-A987-44D7-8D05-95315110063AQ47350013-F9DD015B-AD1E-4B67-9371-9839BA9E78F2Q47995476-983D275A-EF40-43F3-BB63-2AFD77C51586Q48222756-D27A9EF8-55EB-4D69-B88A-6AA5B5A9A660Q48717254-06BDF901-8446-47F4-81FB-FB1C691E4C2EQ48769926-CB31422D-D853-4706-A47C-5D7DBF17D848Q48901724-9C2B5291-3DE2-404F-8EC1-D5895AC9012BQ48923055-86712EB1-FF85-4338-9D87-EBA5D338DE57
P2860
Inhibiting epidermal growth factor receptor improves structural, locomotor, sensory, and bladder recovery from experimental spinal cord injury.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Inhibiting epidermal growth fa ...... perimental spinal cord injury.
@ast
Inhibiting epidermal growth fa ...... perimental spinal cord injury.
@en
Inhibiting epidermal growth fa ...... perimental spinal cord injury.
@nl
type
label
Inhibiting epidermal growth fa ...... perimental spinal cord injury.
@ast
Inhibiting epidermal growth fa ...... perimental spinal cord injury.
@en
Inhibiting epidermal growth fa ...... perimental spinal cord injury.
@nl
altLabel
Inhibiting epidermal growth fa ...... xperimental spinal cord injury
@en
prefLabel
Inhibiting epidermal growth fa ...... perimental spinal cord injury.
@ast
Inhibiting epidermal growth fa ...... perimental spinal cord injury.
@en
Inhibiting epidermal growth fa ...... perimental spinal cord injury.
@nl
P2093
P3181
P1476
Inhibiting epidermal growth fa ...... xperimental spinal cord injury
@en
P2093
Karin Pernold
Lars Olson
Matthias Erschbamer
P304
P3181
P356
10.1523/JNEUROSCI.1037-07.2007
P407
P577
2007-06-01T00:00:00Z